Ladenburg Thalmann Financial Services’s Endocyte, Inc. Common Stock ECYT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-930
| Closed | -$17K | – | 5481 |
|
|
2018
Q3 | $17K | Sell |
930
-125
| -12% | -$2.15K | ﹤0.01% | 4023 |
|
|
2018
Q2 | $9K | Hold |
1,055
| – | – | ﹤0.01% | 4337 |
|
|
2018
Q1 | $9K | Hold |
1,055
| – | – | ﹤0.01% | 4337 |
|
|
2017
Q4 | $5K | Hold |
1,055
| – | – | ﹤0.01% | 4559 |
|
|
2017
Q3 | $1K | Sell |
1,055
-1,835
| -63% | -$2.56K | ﹤0.01% | 4889 |
|
|
2017
Q2 | $4K | Buy |
2,890
+26
| +0.9% | +$56 | ﹤0.01% | 4436 |
|
|
2017
Q1 | $7K | Buy |
2,864
+1,105
| +63% | +$2.56K | ﹤0.01% | 4200 |
|
|
2016
Q4 | $4K | Sell |
1,759
-66
| -4% | -$190 | ﹤0.01% | 4367 |
|
|
2016
Q3 | $6K | Hold |
1,825
| – | – | ﹤0.01% | 4111 |
|
|
2016
Q2 | $6K | Sell |
1,825
-151
| -8% | -$553 | ﹤0.01% | 4078 |
|
|
2016
Q1 | $6K | Sell |
1,976
-62
| -3% | -$202 | ﹤0.01% | 4028 |
|
|
2015
Q4 | $8K | Hold |
2,038
| – | – | ﹤0.01% | 3841 |
|
|
2015
Q3 | $9K | Sell |
2,038
-168
| -8% | -$879 | ﹤0.01% | 3628 |
|
|
2015
Q2 | $11K | Sell |
2,206
-64
| -3% | -$384 | ﹤0.01% | 3652 |
|
|
2015
Q1 | $14K | Buy |
2,270
+66
| +3% | +$381 | ﹤0.01% | 3433 |
|
|
2014
Q4 | $14K | Sell |
2,204
-71
| -3% | -$433 | ﹤0.01% | 3225 |
|
|
2014
Q3 | $14K | Sell |
2,275
-170
| -7% | -$1.16K | ﹤0.01% | 2924 |
|
|
2014
Q2 | $16K | Buy |
2,445
+1,118
| +84% | +$12.6K | ﹤0.01% | 2834 |
|
|
2014
Q1 | $32K | Sell |
1,327
-124
| -9% | -$1.8K | ﹤0.01% | 2262 |
|
|
2013
Q4 | $15K | Sell |
1,451
-175
| -11% | -$1.93K | ﹤0.01% | 2718 |
|
|
2013
Q3 | $22K | Buy |
+1,626
| New | +$25.7K | ﹤0.01% | 2393 |
|
Other funds holding ECYT
Ladenburg Thalmann Financial Services's ECYT Position: Q4 2018 in Review
Ladenburg Thalmann Financial Services sold out of Endocyte, Inc. Common Stock (ECYT) in Q4 2018, closing a stake of 930 shares — an estimated $17K sold.
Ladenburg Thalmann Financial Services first reported a position in ECYT in Q3 2013 and held it in 21 quarters. The position peaked at $32K in Q1 2014. 2 funds tracked by Wall St. Rank hold ECYT as of Q4 2018.
- Ladenburg Thalmann Financial Services reported no remaining Endocyte, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
- Ladenburg Thalmann Financial Services sold 930 Endocyte, Inc. Common Stock shares in Q4 2018, an estimated $17K.
- Ladenburg Thalmann Financial Services first reported a position in Endocyte, Inc. Common Stock in Q3 2013 and held it in 21 quarters.
- Ladenburg Thalmann Financial Services's Endocyte, Inc. Common Stock position peaked at $32K in Q1 2014.
- 2 funds tracked by Wall St. Rank held Endocyte, Inc. Common Stock as of Q4 2018.
Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2018, filed 14 Feb 2019.